Investing.com - Amdocs (NASDAQ: DOX) reported fourth quarter EPS of $1.42, in line with the analyst estimate of $1.42. Revenue for the quarter came in at $1.24B versus the consensus estimate of $1.24B.
Guidance
Amdocs sees Q1 2024 EPS of $1.53-$1.59 versus the analyst consensus of $1.60.
Amdocs sees Q1 2024 revenue of $1.23B-$1.27B versus the analyst consensus of $1.27B.
Amdocs's stock price closed at $83.69. It is down -5.05% in the last 3 months and up 2.42% in the last 12 months.
Amdocs saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Amdocs's stock price’s past reactions to earnings here.
According to InvestingPro, Amdocs's Financial Health score is "good performance".
Check out Amdocs's recent earnings performance, and Amdocs's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar